Recommend the Pain Relieving Power of Aleve® with Confidence

Safety Profile

Safety profile

  • Advance events for OTC Aleve® were not significantly different than placebo, as shown in a large meta-analysis of pooled safety data from clinical trials1 LINK TO STUDY
  • In a separate analysis, adverse event rates for naproxen/naproxen sodium were shown to be no worse than placebo, with 83% of patients treated with naproxen/naproxen sodium reporting no adverse events2
    The most commonly reported adverse events were headache, nausea, and somnolence
  • Very rare (<0.01%) incidence of serious or life-threatening hepatic adverse events when taken as directed, as shown in combined reporting from clinical trial data3
Aleve safety trusted heritage icon
Aleve product annual users
Aleve #1 otc brand for minor arthritic pain

References: 1. Kyeremateng K, Troullos E, Paredes-Diaz A. Safety of naproxen compared with placebo, ibuprofen and acetaminophen: a pooled analysis of eight multiple-dose, short-term, randomized controlled studies. Curr Med Res Opin. 2019;35(10):1671-1676. doi:10.1080/03007995.2019.1612338  2. DeArmond B, Francisco CA, Lin J-S, et al. Safety profile of over-the-counter naproxen sodium. Clin Ther. 1995;17(4): 587-601. doi:10.1016/0149-2918(95)80036-0 3. Data on file. Bayer HealthCare.